Studies have found that serum TGF-β1 levels in patients with Alzheimer’s disease (AD), vascular dementia (VaD), and Parkinson’s disease dementia (PDD) are significantly increased, but serum TGF-β1 levels in AD and VaD are significantly higher than those in PDD [44]. Here, TGFB1 is linked to dementia.